In this episode of Medicine: The Truth, co-hosts Dr. Robert Pearl and Jeremy Corr tackle a wide array of medical issues, from the potential healthcare impact of a second Trump presidency to the latest trends in obesity treatments and respiratory infections.
With a historical election in the rearview mirror, the hosts dive into what a second Trump term could mean for Medicare, Medicaid, the Affordable Care Act and rural health. Among the key predictions: stricter work requirements for Medicaid, potential elimination of ACA subsidies and a likely push toward healthcare block grants for states.
The conversation also spotlights GLP-1 drugs, hailed as breakthroughs in weight-loss treatment. Dr. Pearl explains the pros and cons of these medications compared to bariatric surgery and the shifting dynamics they’ve introduced into obesity care.
Here’s a snapshot of just some of the topics covered on this episode of Medicine: The Truth:
- The implications of Trump’s second term
- GLP-1 drugs vs. bariatric surgery
- Rising prevalence of walking pneumonia
- Ethics of Alzheimer’s drug trials
- Why sitting too long can harm you—and why standing might not be the solution
- An unexpected outcome with advancements in IVF
- Artificial intelligence in diagnosis
Join Dr. Robert Pearl and Jeremy Corr as they unpack these complex healthcare issues and shed light on the path ahead for American medicine.
* * *
Dr. Robert Pearl is the author of the new book “ChatGPT, MD: How AI-Empowered Patients & Doctors Can Take Back Control of American Medicine“ about the impact of AI on the future of medicine. All profits from the book go to Doctors Without Borders.
Fixing Healthcare is a co-production of Dr. Robert Pearl and Jeremy Corr. Subscribe to the show via Apple, Spotify, Stitcher or wherever you find podcasts. Join the conversation or suggest a guest by following the show on Twitter and LinkedIn.
The post MTT #89: Trump’s second term, weight-loss drugs & the rise of ‘walking pneumonia’ appeared first on Fixing Healthcare.
